Dr. Christine Smith, MD

NPI: 1376520387
Total Payments
$104,714
2024 Payments
$48,072
Companies
8
Transactions
65

Payment Breakdown by Category

Consulting$103,895 (99.2%)
Travel$622.16 (0.6%)
Food & Beverage$196.92 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $103,895 51 99.2%
Travel and Lodging $622.16 3 0.6%
Food and Beverage $196.92 11 0.2%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $104,527 55 $0 (2024)
ABBVIE INC. $74.64 4 $0 (2022)
Gilead Sciences, Inc. $28.23 1 $0 (2023)
PFIZER INC. $21.44 1 $0 (2017)
Neos Therapeutics, LP $19.06 1 $0 (2023)
Merck Sharp & Dohme LLC $15.41 1 $0 (2023)
Genentech USA, Inc. $15.14 1 $0 (2020)
Sunovion Pharmaceuticals Inc. $12.70 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $48,072 27 Takeda Pharmaceuticals U.S.A., Inc. ($48,072)
2023 $17,503 11 Takeda Pharmaceuticals U.S.A., Inc. ($17,440)
2022 $26,084 14 Takeda Pharmaceuticals U.S.A., Inc. ($26,060)
2021 $12,531 9 Takeda Pharmaceuticals U.S.A., Inc. ($12,480)
2020 $490.14 2 Takeda Pharmaceuticals U.S.A., Inc. ($475.00)
2017 $34.14 2 PFIZER INC. ($21.44)

All Payment Transactions

65 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $3,000.00 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $3,000.00 General
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $338.35 General
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $10.30 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
06/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,090.00 General
06/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $94.60 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
05/06/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,090.00 General
05/06/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $189.21 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,180.00 General
02/26/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General

About Dr. Christine Smith, MD

Dr. Christine Smith, MD is a Family Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376520387.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Smith, MD has received a total of $104,714 in payments from pharmaceutical and medical device companies, with $48,072 received in 2024. These payments were reported across 65 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($103,895).

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Baton Rouge, LA
  • Active Since 12/30/2005
  • Last Updated 03/14/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1376520387

Products in Payments

  • SYNTHROID (Drug) $42.54
  • LYRICA (Drug) $21.44
  • Adzenys XR-ODT (Drug) $19.06
  • VRAYLAR (Drug) $17.78
  • GARDASIL 9 (Biological) $15.41
  • Xofluza (Drug) $15.14
  • LINZESS (Drug) $14.32
  • APTIOM (Drug) $12.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Baton Rouge